These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Avian pp60c-src is more active when expressed in yeast than in vertebrate fibroblasts.
    Author: Cooper JA, Runge K.
    Journal: Oncogene Res; 1987; 1(4):297-310. PubMed ID: 2453017.
    Abstract:
    Avian pp60c-src, a proto-oncogene product, has been expressed in the yeast, Saccharomyces cerevisiae. pp60c-src from yeast is 10- to 15-fold more active than pp60c-src from mammalian fibroblasts. Extensive phosphorylation of pp60c-src occurs at tyrosine 527 in fibroblasts and inhibits pp60c-src kinase activity. In contrast, pp60c-src from yeast has low levels of phosphate at tyrosine 527. This phosphate may be added by an autophosphorylation reaction that is detectable when immunoprecipitates containing pp60c-src from yeast are incubated with ATP in vitro. This reaction is minor when compared with autophosphorylation at the principal site, tyrosine 416. These data suggest that pp60c-src in fibroblasts is normally inhibited by trans-acting factors, that either directly catalyze phosphate transfer to tyrosine 527 or augment autophosphorylation at this site. Such factors would have the potential to regulate pp60c-src kinase activity. The low but detectable ability of pp60c-src to autophosphorylate at an inhibitory site raises the possibility that pp60c-src may also be auto-regulated.
    [Abstract] [Full Text] [Related] [New Search]